Skip to main content
Multiple SclerosisHealthy volunteersDrug

What this study is

This study involves a Positron Emission Tomography (PET) scan using a new investigational radioactive tracer, [18F]-FZTA, to detect inflammation in the brain. The tracer will be tested in healthy younger adults and individuals with Multiple Sclerosis.

What's being tested

  • [18F] FZTA

    Intervention · DRUG

    Participants will receive a single intravenous bolus injection of 7 ± 20% milliCurie (mCi) of the investigational radiotracer [18F]-FZTA. A PET-certified medical professional will prepare and administer the [18F]-FZTA. Prior to the administration, the dosage will be assayed in a dose calibrator and diluted with 0.9% sodium chloride (normal saline) up to a total 20 mL syringe volume. Participants will receive a maximum intravenous bolus injection of 7+20% mCi of [18F]-FZTA followed by a 10 mL 0.9% sodium chloride (normal saline) flush.

Study details

Official title
Investigation of Inflammation Using [18F]FZTA
Sponsor
Washington University School of Medicine
Conditions
Multiple Sclerosis
Enrolling
80 people
Starts
2025-08-22
Est. completion
2029-12
Record
View on ClinicalTrials.gov ↗